Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 238 entries
Sorted by: Best Match Show Resources per page
Pelvic Organ Prolapse.

American family physician

Iglesia CB, Smithling KR.
PMID: 28762694
Am Fam Physician. 2017 Aug 01;96(3):179-185.

Pelvic organ prolapse is the descent of one or more of the anterior vaginal wall, posterior vaginal wall, the uterus (cervix), or the apex of the vagina (vaginal vault or cuff scar after hysterectomy). Prevalence increases with age. The...

Cite
Iglesia CB, Smithling KR. Pelvic Organ Prolapse. Am Fam Physician. 2017;96(3):179-185
Iglesia, C. B., & Smithling, K. R. (2017). Pelvic Organ Prolapse. American family physician, 96(3), 179-185.
Iglesia, Cheryl B, and Smithling, Katelyn R. "Pelvic Organ Prolapse." American family physician vol. 96,3 (2017): 179-185.
Iglesia CB, Smithling KR. Pelvic Organ Prolapse. Am Fam Physician. 2017 Aug 01;96(3):179-185. PMID: 28762694.
Copy Download .nbib Format: NLM
Progressive ontogenetic niche shift over the prolonged immaturity period of wandering albatrosses.

Royal Society open science

Carravieri A, Weimerskirch H, Bustamante P, Cherel Y.
PMID: 29134098
R Soc Open Sci. 2017 Oct 11;4(10):171039. doi: 10.1098/rsos.171039. eCollection 2017 Oct.

Very little is known about trophic ontogenetic changes over the prolonged immaturity period of long-lived, wide-ranging seabirds. By using blood and feather trophic tracers (δ

Cite
Carravieri A, Weimerskirch H, Bustamante P, et al. Progressive ontogenetic niche shift over the prolonged immaturity period of wandering albatrosses. R Soc Open Sci. 2017;4(10):171039doi: 10.1098/rsos.171039.
Carravieri, A., Weimerskirch, H., Bustamante, P., & Cherel, Y. (2017). Progressive ontogenetic niche shift over the prolonged immaturity period of wandering albatrosses. Royal Society open science, 4(10), 171039. https://doi.org/10.1098/rsos.171039
Carravieri, Alice, et al. "Progressive ontogenetic niche shift over the prolonged immaturity period of wandering albatrosses." Royal Society open science vol. 4,10 (2017): 171039. doi: https://doi.org/10.1098/rsos.171039
Carravieri A, Weimerskirch H, Bustamante P, Cherel Y. Progressive ontogenetic niche shift over the prolonged immaturity period of wandering albatrosses. R Soc Open Sci. 2017 Oct 11;4(10):171039. doi: 10.1098/rsos.171039. eCollection 2017 Oct. PMID: 29134098; PMCID: PMC5666281.
Copy Download .nbib Format: NLM
Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review.

PharmacoEconomics - open

Kolovos S, Bosmans JE, Riper H, Chevreul K, Coupé VMH, van Tulder MW.
PMID: 29441493
Pharmacoecon Open. 2017 Sep;1(3):149-165. doi: 10.1007/s41669-017-0014-7.

BACKGROUND: An increasing number of model-based studies that evaluate the cost effectiveness of treatments for depression are being published. These studies have different characteristics and use different simulation methods.OBJECTIVE: We aimed to systematically review model-based studies evaluating the cost...

Cite
Kolovos S, Bosmans JE, Riper H, et al. Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review. Pharmacoecon Open. 2017;1(3):149-165doi: 10.1007/s41669-017-0014-7.
Kolovos, S., Bosmans, J. E., Riper, H., Chevreul, K., Coupé, V. M. H., & van Tulder, M. W. (2017). Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review. PharmacoEconomics - open, 1(3), 149-165. https://doi.org/10.1007/s41669-017-0014-7
Kolovos, Spyros, et al. "Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review." PharmacoEconomics - open vol. 1,3 (2017): 149-165. doi: https://doi.org/10.1007/s41669-017-0014-7
Kolovos S, Bosmans JE, Riper H, Chevreul K, Coupé VMH, van Tulder MW. Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review. Pharmacoecon Open. 2017 Sep;1(3):149-165. doi: 10.1007/s41669-017-0014-7. PMID: 29441493; PMCID: PMC5691837.
Copy Download .nbib Format: NLM
Erratum to: Validation of the German version of two scales (RIS, RCS-HCP) for measuring regret associated with providing healthcare.

Health and quality of life outcomes

Richner SC, Cullati S, Cheval B, Schmidt RE, Chopard P, Meier CA, Courvoisier DS.
PMID: 28403872
Health Qual Life Outcomes. 2017 Apr 12;15(1):69. doi: 10.1186/s12955-017-0653-5.

No abstract available.

Cite
Richner SC, Cullati S, Cheval B, et al. Erratum to: Validation of the German version of two scales (RIS, RCS-HCP) for measuring regret associated with providing healthcare. Health Qual Life Outcomes. 2017;15(1):69doi: 10.1186/s12955-017-0653-5.
Richner, S. C., Cullati, S., Cheval, B., Schmidt, R. E., Chopard, P., Meier, C. A., & Courvoisier, D. S. (2017). Erratum to: Validation of the German version of two scales (RIS, RCS-HCP) for measuring regret associated with providing healthcare. Health and quality of life outcomes, 15(1), 69. https://doi.org/10.1186/s12955-017-0653-5
Richner, Silvia C, et al. "Erratum to: Validation of the German version of two scales (RIS, RCS-HCP) for measuring regret associated with providing healthcare." Health and quality of life outcomes vol. 15,1 (2017): 69. doi: https://doi.org/10.1186/s12955-017-0653-5
Richner SC, Cullati S, Cheval B, Schmidt RE, Chopard P, Meier CA, Courvoisier DS. Erratum to: Validation of the German version of two scales (RIS, RCS-HCP) for measuring regret associated with providing healthcare. Health Qual Life Outcomes. 2017 Apr 12;15(1):69. doi: 10.1186/s12955-017-0653-5. PMID: 28403872; PMCID: PMC5389438.
Copy Download .nbib Format: NLM
Are Three-Dimensional-Printed Foot Orthoses Able to Cover the Podiatric Physician's Needs?.

Journal of the American Podiatric Medical Association

Allado E, Poussel M, Chary-Valckenaere I, Potier C, Loeuille D, Albuisson E, Chenuel B.
PMID: 34861694
J Am Podiatr Med Assoc. 2021 Sep 01;111(5). doi: 10.7547/20-062.

BACKGROUND: Current management of foot pain requires foot orthoses (FOs) with various design features (eg, wedging, height) and specific mechanical properties (eg, hardness, volume). Development of additive manufacturing (three-dimensional [3-D] printing) raises the question of applying its technology to...

Cite
Allado E, Poussel M, Chary-Valckenaere I, et al. Are Three-Dimensional-Printed Foot Orthoses Able to Cover the Podiatric Physician's Needs?. J Am Podiatr Med Assoc. 2021;111(5)doi: 10.7547/20-062.
Allado, E., Poussel, M., Chary-Valckenaere, I., Potier, C., Loeuille, D., Albuisson, E., & Chenuel, B. (2021). Are Three-Dimensional-Printed Foot Orthoses Able to Cover the Podiatric Physician's Needs?. Journal of the American Podiatric Medical Association, 111(5), . https://doi.org/10.7547/20-062
Allado, Edem, et al. "Are Three-Dimensional-Printed Foot Orthoses Able to Cover the Podiatric Physician's Needs?." Journal of the American Podiatric Medical Association vol. 111,5 (2021). doi: https://doi.org/10.7547/20-062
Allado E, Poussel M, Chary-Valckenaere I, Potier C, Loeuille D, Albuisson E, Chenuel B. Are Three-Dimensional-Printed Foot Orthoses Able to Cover the Podiatric Physician's Needs?. J Am Podiatr Med Assoc. 2021 Sep 01;111(5). doi: 10.7547/20-062. PMID: 34861694.
Copy Download .nbib Format: NLM
Experiential clinical learning for newly licensed PhD students: Transforming nursing PhD education through academic-practice partnerships.

Journal of professional nursing : official journal of the American Association of Colleges of Nursing

Cromeens MG, Britton LE, Zomorodi M, Bevill B, Jones CB.
PMID: 33674107
J Prof Nurs. 2021 Jan-Feb;37(1):43-47. doi: 10.1016/j.profnurs.2020.11.005. Epub 2020 Nov 26.

The growing national and international need for nurse scientists to transform health care has encouraged advances in nursing doctoral programs. The Hillman Scholars in Nursing Innovation, a program integrating BSN and PhD education, inspired the creation of the Hillman...

Cite
Cromeens MG, Britton LE, Zomorodi M, et al. Experiential clinical learning for newly licensed PhD students: Transforming nursing PhD education through academic-practice partnerships. J Prof Nurs. 2020;37(1):43-47doi: 10.1016/j.profnurs.2020.11.005.
Cromeens, M. G., Britton, L. E., Zomorodi, M., Bevill, B., & Jones, C. B. (2021). Experiential clinical learning for newly licensed PhD students: Transforming nursing PhD education through academic-practice partnerships. Journal of professional nursing : official journal of the American Association of Colleges of Nursing, 37(1), 43-47. https://doi.org/10.1016/j.profnurs.2020.11.005
Cromeens, Martha Grace, et al. "Experiential clinical learning for newly licensed PhD students: Transforming nursing PhD education through academic-practice partnerships." Journal of professional nursing : official journal of the American Association of Colleges of Nursing vol. 37,1 (2021): 43-47. doi: https://doi.org/10.1016/j.profnurs.2020.11.005
Cromeens MG, Britton LE, Zomorodi M, Bevill B, Jones CB. Experiential clinical learning for newly licensed PhD students: Transforming nursing PhD education through academic-practice partnerships. J Prof Nurs. 2021 Jan-Feb;37(1):43-47. doi: 10.1016/j.profnurs.2020.11.005. Epub 2020 Nov 26. PMID: 33674107; PMCID: PMC8092922.
Copy Download .nbib Format: NLM
New insights into the biomineralization of mercury selenide nanoparticles through stable isotope analysis in giant petrel tissues.

Journal of hazardous materials

Queipo-Abad S, Pedrero Z, Marchán-Moreno C, El Hanafi K, Bérail S, Corns WT, Cherel Y, Bustamante P, Amouroux D.
PMID: 34894503
J Hazard Mater. 2021 Nov 27;425:127922. doi: 10.1016/j.jhazmat.2021.127922. Epub 2021 Nov 27.

Tiemannite (HgSe) is considered the end-product of methylmercury (MeHg) demethylation in vertebrates. The biomineralization of HgSe nanoparticles (NPs) is understood to be an efficient MeHg detoxification mechanism; however, the process has not yet been fully elucidated. In order to...

Cite
Queipo-Abad S, Pedrero Z, Marchán-Moreno C, et al. New insights into the biomineralization of mercury selenide nanoparticles through stable isotope analysis in giant petrel tissues. J Hazard Mater. 2021;425:127922doi: 10.1016/j.jhazmat.2021.127922.
Queipo-Abad, S., Pedrero, Z., Marchán-Moreno, C., El Hanafi, K., Bérail, S., Corns, W. T., Cherel, Y., Bustamante, P., & Amouroux, D. (2021). New insights into the biomineralization of mercury selenide nanoparticles through stable isotope analysis in giant petrel tissues. Journal of hazardous materials, 425127922. https://doi.org/10.1016/j.jhazmat.2021.127922
Queipo-Abad, Silvia, et al. "New insights into the biomineralization of mercury selenide nanoparticles through stable isotope analysis in giant petrel tissues." Journal of hazardous materials vol. 425 (2021): 127922. doi: https://doi.org/10.1016/j.jhazmat.2021.127922
Queipo-Abad S, Pedrero Z, Marchán-Moreno C, El Hanafi K, Bérail S, Corns WT, Cherel Y, Bustamante P, Amouroux D. New insights into the biomineralization of mercury selenide nanoparticles through stable isotope analysis in giant petrel tissues. J Hazard Mater. 2021 Nov 27;425:127922. doi: 10.1016/j.jhazmat.2021.127922. Epub 2021 Nov 27. PMID: 34894503.
Copy Download .nbib Format: NLM
Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells.

Frontiers in oncology

Chebly A, Prochazkova-Carlotti M, Idrissi Y, Bresson-Bepoldin L, Poglio S, Farra C, Beylot-Barry M, Merlio JP, Tomb R, Chevret E.
PMID: 34765562
Front Oncol. 2021 Oct 26;11:775253. doi: 10.3389/fonc.2021.775253. eCollection 2021.

Sézary syndrome (SS) is an aggressive leukemic variant of cutaneous T-cell lymphomas (CTCL) in which the human Telomerase Reverse Transcriptase (

Cite
Chebly A, Prochazkova-Carlotti M, Idrissi Y, et al. Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells. Front Oncol. 2021;11:775253doi: 10.3389/fonc.2021.775253.
Chebly, A., Prochazkova-Carlotti, M., Idrissi, Y., Bresson-Bepoldin, L., Poglio, S., Farra, C., Beylot-Barry, M., Merlio, J. P., Tomb, R., & Chevret, E. (2021). Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells. Frontiers in oncology, 11775253. https://doi.org/10.3389/fonc.2021.775253
Chebly, Alain, et al. "Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells." Frontiers in oncology vol. 11 (2021): 775253. doi: https://doi.org/10.3389/fonc.2021.775253
Chebly A, Prochazkova-Carlotti M, Idrissi Y, Bresson-Bepoldin L, Poglio S, Farra C, Beylot-Barry M, Merlio JP, Tomb R, Chevret E. Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells. Front Oncol. 2021 Oct 26;11:775253. doi: 10.3389/fonc.2021.775253. eCollection 2021. PMID: 34765562; PMCID: PMC8576518.
Copy Download .nbib Format: NLM
Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial.

The Lancet. Child & adolescent health

Landier W, Bhatia S, Wong FL, York JM, Flynn JS, Henneberg HM, Singh P, Adams K, Wasilewski-Masker K, Cherven B, Jasty-Rao R, Leonard M, Connelly JA, Armenian SH, Robison LL, Giuliano AR, Hudson MM, Klosky JL.
PMID: 34767765
Lancet Child Adolesc Health. 2021 Nov 09; doi: 10.1016/S2352-4642(21)00278-9. Epub 2021 Nov 09.

BACKGROUND: Young survivors of cancer are at increased risk for cancers that are related to human papillomavirus (HPV), primarily caused by oncogenic HPV types 16 and 18. We aimed to examine the immunogenicity and safety of the three-dose series...

Cite
Landier W, Bhatia S, Wong FL, et al. Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial. Lancet Child Adolesc Health. 2021;doi: 10.1016/S2352-4642(21)00278-9.
Landier, W., Bhatia, S., Wong, F. L., York, J. M., Flynn, J. S., Henneberg, H. M., Singh, P., Adams, K., Wasilewski-Masker, K., Cherven, B., Jasty-Rao, R., Leonard, M., Connelly, J. A., Armenian, S. H., Robison, L. L., Giuliano, A. R., Hudson, M. M., & Klosky, J. L. (2021). Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial. The Lancet. Child & adolescent health, . https://doi.org/10.1016/S2352-4642(21)00278-9
Landier, Wendy, et al. "Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial." The Lancet. Child & adolescent health vol. (2021). doi: https://doi.org/10.1016/S2352-4642(21)00278-9
Landier W, Bhatia S, Wong FL, York JM, Flynn JS, Henneberg HM, Singh P, Adams K, Wasilewski-Masker K, Cherven B, Jasty-Rao R, Leonard M, Connelly JA, Armenian SH, Robison LL, Giuliano AR, Hudson MM, Klosky JL. Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial. Lancet Child Adolesc Health. 2021 Nov 09; doi: 10.1016/S2352-4642(21)00278-9. Epub 2021 Nov 09. PMID: 34767765.
Copy Download .nbib Format: NLM
Randomized Clinical Trial of a Self-care and Communication Intervention for Parents of Adolescent/Young Adults Undergoing High-Risk Cancer Treatment: A Report From the Children's Oncology Group.

Cancer nursing

Haase JE, Stegenga K, Robb SL, Hooke MC, Burns DS, Monahan PO, Stump TE, Henley AK, Haut PR, Cherven B, Roll L, Langevin AM, Pickler RH, Albritton K, Hawkins D, Osterkamp E, Mitby P, Smith J, Diaz VR, Garcia-Frausto E, Moore M.
PMID: 34817419
Cancer Nurs. 2021 Nov 23; doi: 10.1097/NCC.0000000000001038. Epub 2021 Nov 23.

BACKGROUND: Parents of adolescents and young adults (AYAs) with cancer offer primary support to their children and often experience their own high levels of distress, affecting parent-AYA communication and quality of life.OBJECTIVE: To reduce parent distress and improve communication...

Cite
Haase JE, Stegenga K, Robb SL, et al. Randomized Clinical Trial of a Self-care and Communication Intervention for Parents of Adolescent/Young Adults Undergoing High-Risk Cancer Treatment: A Report From the Children's Oncology Group. Cancer Nurs. 2021;doi: 10.1097/NCC.0000000000001038.
Haase, J. E., Stegenga, K., Robb, S. L., Hooke, M. C., Burns, D. S., Monahan, P. O., Stump, T. E., Henley, A. K., Haut, P. R., Cherven, B., Roll, L., Langevin, A. M., Pickler, R. H., Albritton, K., Hawkins, D., Osterkamp, E., Mitby, P., Smith, J., Diaz, V. R., Garcia-Frausto, E., & Moore, M. (2021). Randomized Clinical Trial of a Self-care and Communication Intervention for Parents of Adolescent/Young Adults Undergoing High-Risk Cancer Treatment: A Report From the Children's Oncology Group. Cancer nursing, . https://doi.org/10.1097/NCC.0000000000001038
Haase, Joan E, et al. "Randomized Clinical Trial of a Self-care and Communication Intervention for Parents of Adolescent/Young Adults Undergoing High-Risk Cancer Treatment: A Report From the Children's Oncology Group." Cancer nursing vol. (2021). doi: https://doi.org/10.1097/NCC.0000000000001038
Haase JE, Stegenga K, Robb SL, Hooke MC, Burns DS, Monahan PO, Stump TE, Henley AK, Haut PR, Cherven B, Roll L, Langevin AM, Pickler RH, Albritton K, Hawkins D, Osterkamp E, Mitby P, Smith J, Diaz VR, Garcia-Frausto E, Moore M. Randomized Clinical Trial of a Self-care and Communication Intervention for Parents of Adolescent/Young Adults Undergoing High-Risk Cancer Treatment: A Report From the Children's Oncology Group. Cancer Nurs. 2021 Nov 23; doi: 10.1097/NCC.0000000000001038. Epub 2021 Nov 23. PMID: 34817419.
Copy Download .nbib Format: NLM
Social protection expenditure on health in later life in 20 European countries: Spending more to reduce health inequalities.

Social science & medicine (1982)

Sieber S, Orsholits D, Cheval B, Ihle A, Kelly-Irving M, Delpierre C, Burton-Jeangros C, Cullati S.
PMID: 34801334
Soc Sci Med. 2022 Jan;292:114569. doi: 10.1016/j.socscimed.2021.114569. Epub 2021 Nov 15.

BACKGROUND: This study aims to examine whether higher social protection expenditure reduces the negative association of life-course socioeconomic disadvantages with subjective and objective health status and trajectories in later life.METHODS: We used SHARE data from participants living in 20...

Cite
Sieber S, Orsholits D, Cheval B, et al. Social protection expenditure on health in later life in 20 European countries: Spending more to reduce health inequalities. Soc Sci Med. 2021;292:114569doi: 10.1016/j.socscimed.2021.114569.
Sieber, S., Orsholits, D., Cheval, B., Ihle, A., Kelly-Irving, M., Delpierre, C., Burton-Jeangros, C., & Cullati, S. (2022). Social protection expenditure on health in later life in 20 European countries: Spending more to reduce health inequalities. Social science & medicine (1982), 292114569. https://doi.org/10.1016/j.socscimed.2021.114569
Sieber, Stefan, et al. "Social protection expenditure on health in later life in 20 European countries: Spending more to reduce health inequalities." Social science & medicine (1982) vol. 292 (2022): 114569. doi: https://doi.org/10.1016/j.socscimed.2021.114569
Sieber S, Orsholits D, Cheval B, Ihle A, Kelly-Irving M, Delpierre C, Burton-Jeangros C, Cullati S. Social protection expenditure on health in later life in 20 European countries: Spending more to reduce health inequalities. Soc Sci Med. 2022 Jan;292:114569. doi: 10.1016/j.socscimed.2021.114569. Epub 2021 Nov 15. PMID: 34801334.
Copy Download .nbib Format: NLM
The cost of child abuse and neglect in France: The case of children in placement before their fourth birthday.

Child abuse & neglect

Prigent A, Vinet MA, Michel M, Rozé M, Riquin E, Duverger P, Rousseau D, Chevreul K.
PMID: 34058479
Child Abuse Negl. 2021 Aug;118:105129. doi: 10.1016/j.chiabu.2021.105129. Epub 2021 May 28.

BACKGROUND: Despite the high prevalence of child abuse and neglect and its consequences on health, very few studies have evaluated the trajectories of children in placement in France, and there are no cost studies available.OBJECTIVE: To estimate the cost...

Cite
Prigent A, Vinet MA, Michel M, et al. The cost of child abuse and neglect in France: The case of children in placement before their fourth birthday. Child Abuse Negl. 2021;118:105129doi: 10.1016/j.chiabu.2021.105129.
Prigent, A., Vinet, M. A., Michel, M., Rozé, M., Riquin, E., Duverger, P., Rousseau, D., & Chevreul, K. (2021). The cost of child abuse and neglect in France: The case of children in placement before their fourth birthday. Child abuse & neglect, 118105129. https://doi.org/10.1016/j.chiabu.2021.105129
Prigent, Amélie, et al. "The cost of child abuse and neglect in France: The case of children in placement before their fourth birthday." Child abuse & neglect vol. 118 (2021): 105129. doi: https://doi.org/10.1016/j.chiabu.2021.105129
Prigent A, Vinet MA, Michel M, Rozé M, Riquin E, Duverger P, Rousseau D, Chevreul K. The cost of child abuse and neglect in France: The case of children in placement before their fourth birthday. Child Abuse Negl. 2021 Aug;118:105129. doi: 10.1016/j.chiabu.2021.105129. Epub 2021 May 28. PMID: 34058479.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 238 entries